Close Menu

NEW YORK — SomaLogic and academic collaborators have received a $1 million grant from the National Science Foundation to develop new quantum sensing-based methods for proteomic screening, the company said on Tuesday.

With the grant, awarded under the NSF's Convergence Accelerator Program, the scientists aim to develop a low-cost modified aptamer-binding assay on a diamond surface using quantum sensing for simultaneous detection of over 7,000 proteins in a biological sample such as blood or urine.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.